"AI-enabled tools promise improved efficiency, cost savings, better clinical outcomes, and streamlined administrative processes. Yet, their adoption in group health plans raises complex regulatory, fiduciary, and ethical questions, particularly under [ERISA] ... [I]ssues that require immediate attention by plan sponsors and plan administrators alike: claims adjudication, fiduciary oversight, and vendor contracts."  MORE >>